Effects of CpG-ODNs on Phenotype and Function of Monocyte-derived Dendritic Cells in Chronic Hepatitis B

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2011 Dec 8

PMID 22147985

Citations 2

Authors

Xiao-Xing Xiang

Xia-Qiu Zhou

Jun-Xue Wang

Qing Xie

Xiong Cai

Hong Yu

Hui-Juan Zhou

Affiliations

Soon will be listed here.

Abstract

Aim: To study the effects of synthetic nonmethylated CpG-containing oligodeoxynucleotides (CpG-ODNs), either alone or combined with recombinant Hepatitis B surface antigen (HBsAg) polypeptide, on the phenotype, function, and intracellular signaling pathways of monocyte-derived dendritic cells (DCs) in patients with chronic hepatitis B (CHB).

Methods: Peripheral blood monocytes isolated from CHB patients and healthy volunteers were induced to be dendritic cells by recombinant human granulocyte-monocyte colony stimulating factor and interleukin-4. The DCs were then treated with CpG-ODNs, CpG-ODNs/HBsAg, or tumor necrosis factor (TNF)-α for 18 h. The expression of surface molecules including HLA-DR, CD86, and CD1a in DCs were detected by flow cytometry, and the expression of signal transducers and activators of transcription (STAT1, 3, 4, 5, 6) and suppressors of cell signaling (SOCS1, 3) were determined by Western blotting assay. In addition, the capacity of DCs to stimulate allogeneic T lymphocytes and the amount of IL-12p70 released from DCs were measured.

Results: In the DCs derived from patients with CHB, treatment with TNF-α, CpG-ODNs, or CpG-ODNs/HBsAg, as compared to the vector control, significantly increased the expression of HLA-DR, stimulated the release of IL-12p70, and enhanced the capacity of DCs to stimulate allogenic T lymphocytes. The expressions of STAT1/4/6 and SOCS1/3, but not STAT3/5, were upregulated by TNF-α, CpG-ODNs, and CpG-ODNs/HBsAg. In addition, the expression of CD1a was upregulated only in the presence of both CpG-ODNs and HBsAg.

Conclusion: The treatment with CpG-ODNs, either alone or combined with HBsAg, has a remarkable stimulatory effect on the impaired phenotype and function of DCs in CHB, possibly by regulating the expression of STAT1, 4, 6 and SOCS1, 3.

Citing Articles

Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.

Costa J, de Carvalho A, Paiva A, Borges O Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065812 PMC: 11279883. DOI: 10.3390/ph17070964.

Intramuscular primary immunization by nucleic acid vaccine pcDNA/Gpd-IL-2 and enhanced immunization with mucosal adjuvant CpG-ODN and Gpd-IL-2 recombinant protein effectively induced strong mucosal immune responses and immune protective effects....

Zhang X, Zhao T, Zeng T, Wu N, Xiao Y, Liu S Exp Ther Med. 2018; 15(3):2533-2540.

PMID: 29456657 PMC: 5795528. DOI: 10.3892/etm.2018.5689.

References

Kuchtey J, Chefalo P, Gray R, Ramachandra L, Harding C . Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. J Immunol. 2005; 175(4):2244-51. DOI: 10.4049/jimmunol.175.4.2244. View

van der Molen R, Sprengers D, Binda R, de Jong E, Niesters H, Kusters J . Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology. 2004; 40(3):738-46. DOI: 10.1002/hep.20366. View

Flores R, Diggs K, Tait L, Morel P . IFN-gamma negatively regulates CpG-induced IL-10 in bone marrow-derived dendritic cells. J Immunol. 2006; 178(1):211-8. DOI: 10.4049/jimmunol.178.1.211. View

Li R, Chen H, Fei R, Cong X, Sun J, Wei L . [Functions of cultured dendritic cells from patients with chronic hepatitis Beta decreased]. Zhonghua Yi Xue Za Zhi. 2002; 82(13):887-90. View

Gursel M, Verthelyi D, Klinman D . CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells. Eur J Immunol. 2002; 32(9):2617-22. DOI: 10.1002/1521-4141(200209)32:9<2617::AID-IMMU2617>3.0.CO;2-F. View

Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B . Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods. 1996; 196(2):137-51. DOI: 10.1016/0022-1759(96)00078-6. View

Heim M . Intracellular signalling and antiviral effects of interferons. Dig Liver Dis. 2000; 32(3):257-63. DOI: 10.1016/s1590-8658(00)80831-2. View

Remoli M, Ragimbeau J, Giacomini E, Gafa V, Severa M, Lande R . NF-{kappa}B is required for STAT-4 expression during dendritic cell maturation. J Leukoc Biol. 2006; 81(1):355-63. DOI: 10.1189/jlb.0506319. View

Lu G, Tang F, Zheng P, Yang P, Qi Y . Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B. World J Gastroenterol. 2008; 14(10):1617-21. PMC: 2693762. DOI: 10.3748/wjg.14.1617. View

10.

Davey G, Heath W, Starr R . SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens. 2006; 67(1):1-9. DOI: 10.1111/j.1399-0039.2005.00532.x. View

11.

Takauji R, Iho S, Takatsuka H, Yamamoto S, Takahashi T, Kitagawa H . CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J Leukoc Biol. 2002; 72(5):1011-9. View

12.

Latvala S, Pietila T, Veckman V, Kekkonen R, Tynkkynen S, Korpela R . Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol. 2008; 14(36):5570-83. PMC: 2746346. DOI: 10.3748/wjg.14.5570. View

13.

Mellor A, Baban B, Chandler P, Manlapat A, Kahler D, Munn D . Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol. 2005; 175(9):5601-5. DOI: 10.4049/jimmunol.175.9.5601. View

14.

Jackson S, Yu C, Mahdi R, Ebong S, Egwuagu C . Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol. 2004; 172(4):2307-15. DOI: 10.4049/jimmunol.172.4.2307. View

15.

Vicari A, Chiodoni C, Vaure C, Ait-Yahia S, Dercamp C, Matsos F . Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med. 2002; 196(4):541-9. PMC: 2196048. DOI: 10.1084/jem.20020732. View

16.

Ballas Z, Krieg A, Warren T, Rasmussen W, Davis H, Waldschmidt M . Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol. 2001; 167(9):4878-86. DOI: 10.4049/jimmunol.167.9.4878. View

17.

Hahm B, Trifilo M, Zuniga E, Oldstone M . Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity. 2005; 22(2):247-57. DOI: 10.1016/j.immuni.2005.01.005. View

18.

Pilon-Thomas S, Li W, Briggs J, Djeu J, Mule J, Riker A . Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model. J Immunother. 2006; 29(4):381-7. DOI: 10.1097/01.cji.0000199199.20717.67. View

19.

Marschner A, Rothenfusser S, Hornung V, Prell D, Krug A, Kerkmann M . CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells. Eur J Immunol. 2005; 35(8):2347-57. DOI: 10.1002/eji.200425721. View

20.

Arbuthnot P, Capovilla A, Kew M . Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol. 2000; 15(4):357-68. DOI: 10.1046/j.1440-1746.2000.02069.x. View